0001104659-23-121848.txt : 20231129 0001104659-23-121848.hdr.sgml : 20231129 20231129073959 ACCESSION NUMBER: 0001104659-23-121848 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20231127 ITEM INFORMATION: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20231129 DATE AS OF CHANGE: 20231129 FILER: COMPANY DATA: COMPANY CONFORMED NAME: EAGLE PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000827871 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36306 FILM NUMBER: 231448476 BUSINESS ADDRESS: STREET 1: 50 TICE BOULEVARD, SUITE 315 CITY: WOODCLIFF LAKE STATE: NJ ZIP: 07677 BUSINESS PHONE: 201-326-5300 MAIL ADDRESS: STREET 1: 50 TICE BOULEVARD, SUITE 315 CITY: WOODCLIFF LAKE STATE: NJ ZIP: 07677 FORMER COMPANY: FORMER CONFORMED NAME: EAGLE PHARMACEUTICALS INC DATE OF NAME CHANGE: 19880120 8-K 1 tm2331615d2_8k.htm FORM 8-K
false 0000827871 0000827871 2023-11-27 2023-11-27 iso4217:USD xbrli:shares iso4217:USD xbrli:shares
 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 8-K

 

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): November 27, 2023

 

 

 

Eagle Pharmaceuticals, Inc.

(Exact Name of Registrant as Specified in its Charter)

 

 

 

Delaware 001-36306 20-8179278
(State or Other Jurisdiction
of Incorporation)		 (Commission
File Number)		 (IRS Employer
Identification No.)

 

50 Tice Boulevard, Suite 315
Woodcliff Lake, NJ		   07677
(Address of Principal Executive Offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (201) 326-5300

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.001 per share   EGRX   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

 

Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

 

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

 

On November 27, 2023, Eagle Pharmaceuticals, Inc. (the “Company”) received a delinquency notification letter (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that due to the delay in filing the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2023 (the “Form 10-Q”), the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Rule”), which requires listed companies to timely file all periodic financial reports with the Securities and Exchange Commission (the “SEC”).

 

The Notice provides that the Company has 60 calendar days from the date of the Notice, or until January 26, 2024, to submit to Nasdaq a plan to regain compliance with the Rule. If Nasdaq accepts the plan, Nasdaq may grant the Company an exception of up to 180 calendar days from the due date of the Form 10-Q, or until May 7, 2024, to regain compliance. The Company may be able to regain compliance with the Rule by filing the Form 10-Q with the SEC (and any other reports required to be filed) before the end of any such exception period. If the Company fails to regain compliance prior to the expiration of any such exception period or if Nasdaq does not accept the plan of compliance, Nasdaq will issue a determination indicating that the Company is subject to delisting. If that occurs, the Company may request a hearing before a Hearing Panel to review the determination. However, there can be no assurance that Nasdaq will accept such plan or grant an exception period, that any hearing would be successful, or that the Company will be able to regain compliance within the deadline or any exception period that may be granted or maintain compliance with the other continued listing requirements set forth in the Nasdaq Listing Rules.

 

Item 7.01 Regulation FD Disclosure.

 

On November 29, 2023, the Company issued a press release announcing the Company’s receipt of the Notice. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

 

The information furnished under this Item 7.01, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, and shall not be deemed incorporated by reference into any of the Company’s filings under the Securities Act of 1933, as amended, or the Securities Act, or the Exchange Act, whether made before or after the date hereof, regardless of any general incorporation language in such filing, except as shall be expressly set forth by specific reference in such filing..

 

 

 

 

Forward-Looking Statements

 

This current report on Form 8-K contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, and other securities law. Forward-looking statements are statements that are not historical facts. Words and phrases such as “anticipated,” “forward,” “will,” “would,” “could,” “may,” “remain,” “potential,” “prepare,” “expected,” “believe,” “plan,” “and similar expressions are intended to identify forward-looking statements. These statements include, but are not limited to, statements with respect to: statements relating to the Company’s SEC filings and the timing thereof, the potential submission of a plan to Nasdaq and the potential for Nasdaq to accept such plan or grant the Company an exception period or the success of any hearing process, and the Company’s ability to regain compliance with the Nasdaq continued listing standards. All of such statements are subject to certain risks and uncertainties, many of which are difficult to predict and generally beyond the Company’s control, that could cause actual results to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. Such risks and uncertainties include, but are not limited to: the completion of the review and preparation of the Company’s financial statements and the timing thereof, the discovery of additional information, further delays in the Company’s financial reporting, including as a result of unanticipated factors, the possibility that the Company is unable to regain compliance with, or thereafter continue to comply with, the Nasdaq Listing Rules, or experience violations of additional Nasdaq Listing Rules, the possibility that the Nasdaq may delist the Company’s securities and the risks and uncertainties set forth in the sections entitled “Risk Factors” in the Company's Annual Report on Form 10-K  for the year ended December 31, 2022, and in its Quarterly Reports on Form 10-Q for the quarters ended March 31, 2023 and June 30, 2023, as well as subsequent filings with the SEC. The Company does not give any assurance that it will achieve its expectations. Readers are cautioned not to place undue reliance on forward-looking statements. All forward-looking statements contained in this current report on Form 8-K speak only as of the date on which they were made. Except to the extent required by law, the Company undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit
No.		   Description
99.1   Press release dated November 29, 2023.
104   Cover Page Interactive Data File (Embedded within the Inline XBRL document)

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: November 29, 2023
  EAGLE PHARMACEUTICALS, INC.    
   
  By: /s/ Brian Cahill
    Brian Cahill
    Chief Financial Officer

 

 

 

 EX-99.1 2 tm2331615d2_ex99-1.htm EXHIBIT 99.1

 

Exhibit 99.1

 

 

 

Eagle Pharmaceuticals Announces Receipt of Notification of Deficiency from Nasdaq Regarding Requirement to Timely File Quarterly Report on Form 10-Q

 

WOODCLIFF LAKE, N.J. — November 29, 2023 — Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (the “Company”) today announced that it received a notice (the “Notice”) on November 27, 2023 from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) advising the Company that it is not currently in compliance with Nasdaq’s continued listing requirements under the Nasdaq Listing Rule 5250(c)(1) (the “Rule”), which requires timely filing of all required periodic financial reports with the Securities and Exchange Commission (the “SEC”), as a result of the Company’s failure to file its Quarterly Report on Form 10-Q for the quarter ended September 30, 2023 (the “Form 10-Q”) within the prescribed timeframe.

 

The Notice provides that the Company has 60 calendar days from the date of the Notice, or until January 26, 2024, to submit to Nasdaq a plan to regain compliance with the Rule. If Nasdaq accepts the plan, Nasdaq may grant the Company an exception of up to 180 calendar days from the due date of the Form 10-Q, or until May 7, 2024, to regain compliance. The Company may be able to regain compliance with the Rule by filing the Form 10-Q with the SEC (and any other reports required to be filed) before the end of any such exception period. If the Company fails to regain compliance prior to the expiration of any such exception period or if Nasdaq does not accept the plan of compliance, Nasdaq will issue a determination indicating that the Company is subject to delisting. If that occurs, the Company may request a hearing before a Hearing Panel to review the determination. However, there can be no assurance that Nasdaq will accept such plan or grant an exception period, that any hearing would be successful, or that the Company will be able to regain compliance within the deadline or any exception period that may be granted or maintain compliance with the other continued listing requirements set forth in the Nasdaq Listing Rules.

 

About Eagle Pharmaceuticals, Inc.

 

Eagle is a fully integrated pharmaceutical company with research and development, clinical, manufacturing and commercial expertise. Eagle is committed to developing innovative medicines that result in meaningful improvements in patients’ lives. Eagle’s commercialized products include PEMFEXY®, RYANODEX®, BENDEKA®, BELRAPZO®, TREAKISYM® (Japan), and BYFAVO® and BARHEMSYS® through its wholly owned subsidiary Acacia Pharma Inc. Eagle’s oncology and CNS/metabolic critical care pipeline includes product candidates with the potential to address underserved therapeutic areas across multiple disease states, and the company is focused on developing medicines with the potential to become part of the personalized medicine paradigm in cancer care. Additional information is available on Eagle’s website at www.eagleus.com.

 

 

 

 

Forward-Looking Statements Disclaimer

 

This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, and other securities law. Forward-looking statements are statements that are not historical facts. Words and phrases such as “anticipated,” “forward,” “will,” “would,” “could,” “may,” “remain,” “potential,” “prepare,” “expected,” “believe,” “plan,” “and similar expressions are intended to identify forward-looking statements. These statements include, but are not limited to, statements with respect to: statements relating to the Company’s SEC filings and the timing thereof, the potential submission of a plan to Nasdaq and the potential for Nasdaq to accept such plan or grant the Company an exception period or the success of any hearing process, and the Company’s ability to regain compliance with the Nasdaq continued listing standards. All of such statements are subject to certain risks and uncertainties, many of which are difficult to predict and generally beyond the Company’s control, that could cause actual results to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. Such risks and uncertainties include, but are not limited to: the completion of the review and preparation of the Company’s financial statements and the timing thereof, the discovery of additional information, further delays in the Company’s financial reporting, including as a result of unanticipated factors, the possibility that the Company is unable to regain compliance with, or thereafter continue to comply with, the Nasdaq Listing Rules, or experience violations of additional Nasdaq Listing Rules, the possibility that the Nasdaq may delist the Company’s securities and the risks and uncertainties set forth in the sections entitled “Risk Factors” in the Company's Annual Report on Form 10-K for the year ended December 31, 2022, and in its Quarterly Reports on Form 10-Q for the quarters ended March 31, 2023 and June 30, 2023, as well as subsequent filings with the SEC. The Company does not give any assurance that it will achieve its expectations. Readers are cautioned not to place undue reliance on forward-looking statements. All forward-looking statements contained in this press release speak only as of the date on which they were made. Except to the extent required by law, the Company undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made.

 

Investor Relations Contacts:

 

Lisa Wilson

In-Site Communications, Inc.

917-543-9932

lwilson@insitecony.com 

 

Timothy McCarthy, CFA
917-679-9282
tim@lifesciadvisors.com

 

# # #

 

 

 

 EX-101.SCH 3 egrx-20231127.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 egrx-20231127_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 5 egrx-20231127_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 6 tm2331615d2_ex99-1img002.jpg GRAPHIC begin 644 tm2331615d2_ex99-1img002.jpg M_]C_X 02D9)1@ ! 0$ 8 !@ #_VP!# $! 0$! 0$! 0$! 0$! 0$! 0$! M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_ MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P 1" !( .<# 2( A$! Q$!_\0 M'P 04! 0$! 0$ $" P0%!@<("0H+_\0 M1 @$# P($ P4% M! 0 %] 0(# 01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D* M%A<8&1HE)B7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#^CO\ X*D? MM2_M_P#[&FCV/QD_9\\&?"'X@? N+3DM_B#-XG\&>*-2\1_#34EO;2SL]5U* M[T3XC:!:ZEX3UJYOS FHV^@V\_AZ_MFL-8NKJVN]*G3\*%_X.,?V] #X*_9 MI4CAE;P'\1 RL."K _%C*LI!#*<%6!! (-?VO^)O#?A[Q7X>UWPYXFT;3-?\ M/Z[I=_I6LZ+J]G#J&EZKI>H6DME?V-_9722V]U:W=G-):W$,Z.LL$CQ.&1F% M?Y5SJH3Y05/RX$812&8J<8,4JK&6^5]L>[9N$31R;77^J?H]9-P7QSE^>'4<3!5(Q^L4YQ;YZ<4I4K)IS5W_/7B[F M'$'#6)PF.R[/\RA0S'V\U@J=54XX:5!PA*G0E&-W2ES*2C.[4KMNVB_?+_B( MQ_;T_P"A+_9F_P"!> ?B$?R)^+&W_"!_$-?Y M?%=L_3 Z#GM7O/\ P32_X(N?LQ?ME?LC^"/CW\2O'GQWT'Q=XGU_QUIE]I_@ MCQ+\/M.\-QP>&O%NJ:%9265EKWPQ\2ZK"7M;*(3K.Q. KSPV35I4 M9U<-4]E4E1K1Q*;@Y:QDHZI--7VX\NR/Q;S# X3'X3/*LL/C,/2Q-"57,HI^ MSJQ4X\]&I;6UTXR>C5]K7_(Y_P#@XR_;T92#X(_9F R"2/ WQ$W8# D#'Q5 MSC(7<&3)!=)%W(W]L/@[4KG6/"OAW6+P0K=:MHVF:G.+>(Q0)-?6,%S)'"A: M1Q%$SE(P[R.$"AI'QO/X(#_@VX_8H"G/Q6_:E8X;C_A,OA.>,$8P/@J,GKC# M*0<$,#R/W]\.Z3#HFAZ7H4,LEQ;:-8V>F6TT[JUQ);V-M%;1/=&.&WA:X=(5 M,S000PLS%HXT!P/Q+Q1SSPUSB>3?\0]R.KDCHRQ,L9&I##RPMJL*T8RIS;FI.FW9M/1*S M;WNCI?7!]1[9]>.1Z'_.?P'_ ."KG[:/_!0?]A;7X_B=\+O!?P)\9_LUZ[/I M6DP>)/$OA#QG>^*_!'BNYMYHI-&\7'2_B-HNGS:5JLML]SX?\1V^FV-FTU[_ M &'JWE7\.E3ZO^_'8]!_GG/(]^]?BY_P71_:"M/@A^PMX[\/VT6CW?BGXZ:M M8_!_0K/4[6TOVMK'6[.^U/Q?KD-C>>8CW&G^&=*NK33=0CC5]$US4=)U**47 M26B5\WP'"G7XOX?P%;)L+GU#,+%'%-.Q73-'N5M;?R MV>ZU&YLM-1M]S"K['P,^+6K_ +^-'PL^,OAW?-K'PQ\?>%/&MG;P3F%KQ=" MU:SU.[T]I5#H;?5=+BNM/NHY,I+<'F M>3XG,,TQ];*YX_#P<*R4Z6)IQK0IUH>V:3E.C[13JR;^..BM8_U(;8)B,QD; M2H*]L@JQ4XPO4-D\9SG))&:N%?'GA?0O%_A^^CV@SZ3K^G1ZA8F9$9A#<+!*8KFW+;[>XCF@8!D9:]'>1 M(P6=PH SN/0 YQST/0]_3U&?\[^2K1G5H5H2CB*,YTJU*2:JQQ%.4H5XSB[6 ME[=3BK*VB3U/[%IU:=>G&M3DITJJ56$TTXN-3]Y=-;V3?-_V]YGD_P 6?C-\ M-O@9\//$OQ5^*_BO3O!/@+P=I9U3Q!K^K,XALK9[B.QMXX[:U6>]OKV_OYH= M/TK3K"WNK_6-1GMM/TFVO+VYMK>;^7#]J7_@X]\30^*]2\._LC?"+P[+X;TZ MI2VWP]T+5="?1%MKN/9ILNNZ]J%_-&LK7^AZ-<2/ M;1_GA_P61_;K\0_M5_M)>)?AIH%^UI\%/@/XHU_P;X7TRPU2ZN+'Q=XHT6\; M2M?^(6KQ((K*>YNKFUDTKPS&JW*67AVPMM0@N!)KURB^&?\ !/;_ ()L?%K] MOWQGJVG^&K]/AU\+/"$0D\7?%?4_#M[J>C6U\?LOV?P9X>M$GTVRU_Q-&P]Z<:<[\KDIM?SQQ+XC\0YYG[X9X'I+F ME6KX.56E3A+$U\11J2IU73K5)*EAJ,8PJ5%5O[2\7'1-)_1K_P#!?'_@HJUR M;A?&GPWCC+EA8K\,=!-H%*;0A:9I[V0*26!EO)9,?A-%K'AWQ5HEL_$^J2^&M?U[6="\2S1DF:2 MTM-1\(*8U?[(RRK#$WVQIO\ P;:?LE'15@U7XT_M%S^(?L_EOJ^EZK\.-.T; M[3Y9 O+;0[[X;:Y=QG(#M:W.M7$6\E8VBP8Q^0/_ 4$_P"")'QB_9 \*7OQ M=^%?B2]^/'PETIM0N?%#CPX-(\=?#[2+2#[3#K.M:3I]]>6&N>'H$C)U7Q18 M+IKZ2BFZU+P_::?'/>#T\)F?T;.-<74R&CDU'(<164\/@<<\)BLECBZ\G4IT M)4:TTZ>#J5*BBZ?UQPI2J.*J+]]<\W$X'Q@X9H1S3Z]7QD*3]M6HU<;#'Q]U MN3I5\)-J512O[)J-I0YU._+!7_M!_9^_:)^#W[3_ ,-M$^*7P1\867C3P5JD MUQ9QWT-O=VMWIVIZ?Y9OM(UO2M1BMM5T?6K'S()9K+4K:.9HKFSOHWGLK^SN MKG\]O^"IW[0G[=?[)G@NU^.7[-'ASX.>./A%X;T;/Q9TGQKX;\4:OXS\'R+J M"QV_BNQN-&\>^%;75O"^ET3XA_P""!O[" M/QO^"-AJ?[2WQ'\6>)_!7AKXJ>&;G1M!^!]S9WMBFOZ>M];7.D_$;QI8:H"^ MFWX6TOD\*6=M8V>H3:;JESJ=WJ9TF_TS2YOZ4M4TG2]5L[S3]4T^SU&PO[2> MSOK&^MXKNSO+6XA>&>UN[:=7@N;:>)WCF@GC>*6-W1T9&*G^<<[PV0<$\=8O M#Y;5P?&>297BXTYK&X:M2PN.I\JEB>#FZN%>,H-4:E>GST'*DGS? MM&4U\VXIX3IXC&PK<.9EC<-*2CA:CE[&M"+4:T(S5X4JDHINC>\;2:E[T3^( M=O\ @XV_;US@>"?V:.@.6\!_$1,YR,8/Q6#$@J,-2\;>,?#\UKX)T_6-,T!+'0+NWM+(VMAK6N>( MKN"YE2>9KJ;^TC'.P1A;ID;/X(/VE]&TGP[^TG^T)X?T'3;+1]#T+XX?%?1M M&TG3K>*TT_2])TSQQK-EIVG6-K"J0V]G86=O!:VEO&JQV]O#'#$JQHJC^TG_ M (-^O^4>N@>WQ8^)@'L#J5N3^9 /U K]^\5/$\B;TYXK3E>GY+X9\3<1YGQCB\IS;.<3C:.% MI9A2<))*$JN&KU/7: 3]>/\ ]?6GRX 4 MGG:?QSCMV[YZTD/^K![DC/XD _I4Q4-U&<>M?R J:5&--6LJ<5'FBI)6C>+< M6[-QO%I7MS15[I:_T;&]HO1NT&_NBG]\4_FS\SO^"C7Q-_;;^!WPO'Q>_9 \ M)_#[XBR>%)[FY^(7@/Q=X8U_7=;D\+16-Q<7'BOPLN@^,O"EQ?W.A& C5O#J M6VJWEUIKKJNEI-<6LUJ/YH&_X.,_V] 1M\%_LS$%%)7_ (07XA$?,NX X^*Y MS\K*0P;:X(9=R%6/]P5Q96LL;^9!&^]AOW+D/M)"EQT%O!V@Z3X8\,Z1\4=372= T.R@TS2-,CN['3[^YAT_3[5 M([6R@DN[NYN!!;11PI)-(41 V*_IKZ/N5\*<7X['\-\3\+Y9FF(P6"J9CAB6OZ%_\1&7[>?_ $)/[,G_ (0/Q#_^ M>S0?^#C+]O//'@K]F4>W_" _$$XX_P"RL]^N#SSVZ5'_ ,$B?^"6'P#_ &^O MA;\5?'OQ?\;?&/P[J/@;Q]:>$M)LOAOKG@G2-+GL+CP]8:O+)OAYXLOY M[_[7=3)'+!J-O9K:+&%M5ERU?KG_ ,0W'[$[8(^*W[48!YP?&/PE/_CW_"D] MW/7OUZD5]MQ/G/T=>%\]S+AW'\$5WF&58N>%Q4J.3XC$X:4J<:UM3Y?)H\!_$)1CTP/BOC/'7CCBOZ,O W[7GQH\6?\$__ ((_ MM,V_@WPOK?Q6^*&B::+BSTVRU:R\&:3KNKMXCM](A^PG5KO6!_PE7B33]%^' MOA6*75[PIXR\;Z";N26REN@?CO\ XAN/V),@'XK?M3 \\CQI\)\?@!\$\^OU MQU'?]E_@!^SSX$^!GP,\&_L[Z*-3\6_#WP'X;/A33AX_71M9U/6-)^T3W+C7 M1IVDZ5HEZ9I+VYCE$>B6,4\&Q#9HJL&_&?$?B+PJS3#Y(^ .&ZV68C"9C[3- M5B,NK8&GB:$8)J$'5K24XRFG&3I7BE)N]KV_1>#\E\0,%5S*/$>;*M1Q&"G2 MP4OK=+$3P^(FY)3E[W/-QBU)-+FNDVK1. _8M^,OQ ^.GPHLO&/Q1\-:5X2\ M90ZQ)I>KZ-HEMK5GIMO?_P#"/Z3J&JV=O%K]M8ZC*WA[7;O6/!]_?-96L.IZ MOX:O[Y-/\/7;ZGX;TPKZST7P]H/AS3K+2?#VBZ7H6E:=%Y-AIFCV-MINGV4. M9&\FVL[..&WAB#32L(XXU0/([A0S$DK\BQ-2G5Q%>KAZ2PE"K5J5*6&I/]W0 MA.3DJ<+\S:5WJV]6^A^E82A5HX:A2Q-5XO$4Z5.%7$U-*E><8J+J2LK7=NB6 MB5];B7*[()AG.8Y%^F$)SG.3]W&#V/K7^4QP?O_ZJ4_[$WZQO_A7^4L.GXG^9]C7]6_1)2CC.-YM-J& R*$N57ER MUL1CE)13NFY5G1>J>J26C:/P/Q\5\/PXU.,)7QKYI_![M2G=2\FM&U9ZJUF? MTG_\$X/^"U7P%_8R_9/\$_ +QQ\+_BOXG\1>&-<\;ZK=:QX6C\(G1IX?%'BO M5?$-M'!_:WB73;Y9+>#4$@G$]E 1+&V%P1C[J_XB4_V5O^B(?'C_ +]_#_\ M^;.OPZ_9*_X(O_M2_ME_!#P[\?/A=XY^ NB>#O$VI>(]+L--\=^*OB!I?B6* MX\,:Y?>']0:[LM!^%_B;3(X9;S3YI;1H-8N&DM7B>9+>9G@C^E1_P;<_MSGC M_A9_[*G_ (7?Q8_^/.I1U3Y5=/:^I^MOPL_P"#A/\ 9I^+'Q/^''PLT/X.?&K3M:^) M?CWP?\/](O\ 5(_! TZSU+QEXAT[PY8W5\;+Q=<70M8+K4HI)_(AD?RU;"]3 M7[\6SL5WYCSN.-IRI5E#+SG#':5.X'!X )[_ ,?/[/?_ ;[_MF_"GX^?!#X MI>(_B/\ LS7?A_X:_%_X:^/M>M-&\:_$^XUBZT;P9XST7Q'J=MI,%Y\'-.LI M]3GLM-GBL(;O4;&UENGB2XO+6%GG3^PM+=XU !0E2S9RP!!)('3C.,$#(XS7 M\]>)>6^'V79I@Z7AQF*S'*ZF"G/%S=2O5]EC>>:BI5,10H54G!0<8QCR[MN^ MA^N\#XWB_&X7&SXMP-+!8J&(I1PJA2>'A+#QMX'_9WT M?(MFCEBO?B'XWT[2_$'BV\>X4@N;'2U\'Z UO(2-+O\ 3]7. US:K=P0Z=9! M0S-NWT^H:Q.MC;O\ 9[&-[Z>?R+&W>2WLH@EM"\\,*L_ZG]&/A66:\49AQ5B: M4%@N&Z/U;#3J)-2S#,\#B*BJ^]HOJF&.&>O"Y1EV04G'VF: MU*N*Q"4FISP^ Q5*U-6:24ZD53M>.N_-=G]0?_!N+^S+IUQI?QD_:P\0Z?+/ M=W5\OP7\ /<6S_94T^&ST_Q1X^O46=0MV]U=7'AC1DGAB"6ESI.O::\DTDDT M47\_?[<_[/\ -^S-^UG\&]3M;0W,#36QN;:>T60S:=-''^R/['W_!$/V5/% M&HV/@G2"=8UMOBGIEM)XD\7:M/)JWB_Q'+!)X+NGMQK'B*\U"[L[0W$BZ=IS MV6FQ,8K.,U^>/_!3;]O#P+^W]\1/AW\3O#OP>U7X5>*/"WA+4/!WB:ZU+Q9: M^*%\2Z2FJ_VSX9CA^S:'HRZ>=#O-3\4EV83O>IK$ E)>'\7. M(^(HN M,>57O_2/_P &^?[3.F?%+]DN?X$:AJ4;^-_V>?$>IZ?]@G=FOKGX?>,]2U#Q M+X8U9&9$62VMM8N_$?AU;:-YFT^UT?36N'ABU+38G_73]K+XK:G\%?V9OCY\ M7-&$#:Y\.?@[\0/&.@0SJ'ADUWP_X7U:^T995P^^)]62P61=ARH(ZD"OX>_^ M"*W[3FG?LT_MS>"$\4ZE/8^!_C79S?!?7W11+;6NK>+-0TM_ VH3Q.XCC4>- M;#0],N]15X#IVDZG?W4S2VZRQG^T;]OCPQJ_CG]B3]K'PQX=M9;W7-6_9_\ MBJNBVEO&+BZO=5B\%ZS=Z9:64"DBXNKVYA2UMX]WSW$D4;;06*_SGXO\)T>& M?%J<'1]GE&>YAEV;4VTUA_98S,<(\SHPDKVC"M+$.:NW&-227N\J7[-X=<0U M\YX E4=22S#*L-F>$J1]UU82I1J2P=64;6O*G./(_>32U5T?YJLTD]U<7-W, M[SW%Q*]S [#XL:O=K%'YNI:A\4#)XP@OKB4*#*T6AZOH^D6LA&]--T MRPMBS+$H7_.R=B1M&]00"_ RZJ[,J 9&29H 01P6C1@=DB,_^D7_ ,$RO'6C M^._V!/V1-2TB19H=,^ _P]\(W!BQY<6I?#_18_ &KPD,P=3'J_A>_BVNBR@J M/.CAD)C3]L^D_4Q5+A?@NAA[?V3/$3YZE-S4)56X4[?AZ]_X*;_\$\=0B,%W^UE\%YX'5TDA?Q'! M+'+'(A1T='MVC=9(R\;I(KHT3R*T98JR>X_MF>$_$7Q _9._:?\ '@W2+K7 MO%_C?]GKXR>%/"^CV;0+/JWB#Q#\.?$FC:+ID+3S0QK/J&I7UK9P-*Z1>9,/ M,D08)_S\/C=_P3V_;(_9P\#3?$KXV? W7/ 7@FWU33M&EU[4/$/@C4;>/4]6 ME:'3[5H-#\3ZK>*;F2,JKFW\I2/G=>_X+X5>'W#G'E?'X7/>*O\ 5ZO2KX&E ME=!/"U,1CJU>JX3C1I8F?MJE6$WS*-/WE)1M;E3/U#C_ (OSKA:.%_L[**69 MT:T,76QDZD)U8X>,(J5*=5QC**4DFDV[V=WJD?WI_#W_ (*"_L4?$CQAX?\ M 7P]_:1^%GB[QIXFOQIOAOPWI&NQW&JZO?R0S2I8V,26QDFE:..1T5G9W\LF M21CEZ^UQ*)5+K@J#)'GU,99'.,D#$@8#!;IUSG'^<9_P2JY_X*'?LFX(P?BG M8MPR.N/[)U4C#(60@KTPQ'/7GC_1P$@,3D?W<_DH7CCJ.3VKC\7?#_!^''$& M'R7!YEBLUAB,M6/GB<9AXX>I[1U:]&I"-.#:=.')&7-HW*;;3UD=7AUQ?7XO MR6OCL3A:&%EAJ];#1I4')P]G""G[2TK.+ZG8_S"?VL/\ DZK]IK_L MX+XR_P#JPM>_S_4U_9M_P;\_\H]=!_[*Q\3/_3C!7\9/[5_/[57[31]?V@OC M+_ZL+7J_LV_X-^A_QKVT$9Q_Q=7XF/\ @=3MEP.",Y;OC@'O@'^DOI!*_@UP MNDKR=3A:,4K7;EPMA$DE=;W2W/QGPK37B3FS::@YYW;3>3Q^(=M+]-C]QX?] M4OU'\Q4]5X?]6 2!TQG'4'Z].!^?X5/N&<=?ITQ[\_Y_4_PXG>":U3@O_2$N M_>+7JC^J(_#'_#'_ -)C_737^CQ*Q^1-?YP__ 55_P"4B/[6?_95+O\ ],NC5_2WT7)6 MX]S/M_8+OZ?VO@K^6L>9:W6OJC\0\=E?AW*;[?VJ[^GL'>_RN_EYGVE_P28_ MX*K_ @_8 ^&'Q1\!_$?X??$3QGJ'CGQ_:^+=-O/!,?AIK.QLK;P[IVDM;7Y MUO7M+E-S--#)/']FBGMC:O&1<$MEOUC'_!RE^RL!@_ _X\@]PT?@#(_/QGFO MY\/V'_\ @EG^T'^WUX*\8^//@YXN^#OAW2/!'B:#PGJUO\2O$7C/1-1GU"XT MNWU=)K"+PU\/_%]K+9?9KB-&EN;VUG\]9%^S&/;*_P!P?\0W7[,>(,1Q1Q!/"9_6S"K5S3!K%5*=.ABVG&4 M?9X# 2A"HZ?L6XP?LU%[JI*9\=P_G?BS3R?+8Y%E-'$Y32PZI8.I/+K>TIJ3 M:FFJT$XV5KVO>[ZGZ8?\1*/[*Q.?^%(?'GC_ *8^ CZ] /&17)SU."!Z\"OZ M'/!NN6WBCP_H?B:SC>"V\1Z%I.O6L$P N8+76+&WU""*X56=%GBCN4294DE0 M.HVL!C/\6)_X-N?VY\C_ (N?^RH#S@GQU\6#CWQ_PI#KQM'U-?VD?#WP_>>% M/ _@[PSJ$MM-?>'O"GA[0KV2SDEDM)+O2=+MK*XEM7GBMYGMWEA9H7FMX)6C M*EXHVRH_GOQ0R?PLRVMD\O#;-9YO&I#$/,_:<]58*46EAXTJE>A0JJ+3E9N+ ME*[YK65_UO@3,.-\=+,(\8991P*IK#O!2ITE3]K-\RKRY7*HX.W+>"DDM+:- MG94445^7'Z,8MT2T,O?"3$\?[#XST['^?I7^4NI! (.0W(]PQ^4_CFO]62^E M:.W88&UHG65NI4- ^6VKEL!]NX@$(NYF 0%A_E,0!GAAR(T#PQL8Y9$CEB+1 MAC')'(\$5WES>Z?V??\$;?VYOV1/@;^P/\,?A[\6_V@OAI\/\ QMI_B;XFWU_X M:\2Z]'8:M;6FK>/]?O\ 3;B2W:-BL5W9S17$+ G='(,X.57]3/\ AZ'_ ,$^ M#S_PUQ\%1D=#XI@X_P#(?\N?>O\ -["%>/-C'<_Z1;\]L\-Z YY)!/<4[RY M?^>T7_?^#_X[7VN??1YX7SO.\WSBKQCCJ%3-<*,7%2E;+ M4E)IMNRMV2/]()?^"H7_ 3Z) '[7/P7)) P/%D(R#P 4(SQQCKTQDU]O>' M?$FA^+= T;Q1X;U.VUCP_P"(=+T[6]$U:SD\RSU/2=6LH-0TS4+610/,M;VR MN8+F!\#?%*C8&17^4Y(KHK,TMN5 Q^\N(@@)^4,2D\;94D,H#@E@N >A_P!. M']D%F'[*7[-BX*A/@-\(H^&W8V?#_P /(,DD\[0 P8[@V[/<5^$>+GA?E/AW MALFJY5G=;.IYE7QU.O3KSR^FZ,,-2A.FZ:PM:OK4E-Q_4JSDIQFL30H-J,5>/)!W;MSO9?AU_P<7? MM.ZEX*^"GPT_9K\+ZJ+>\^-&OWOB;QW# 9$NCX&\ 3:3>:7IT\B%3#;:[XSO M=*O1Y91YH?#5U;ES;_;()?YKOV!/V.]:_;D_:-T+X"Z5XCE\&:=-X:\3^*O% M'C2'0D\1'PWH?AW3I_)O%T'^U-"2]&H^(;SPSX?5#JMFMO\ VQ]LC\X6QM9O M4?\ @K#\>-=^/_[>'QWU:\UE-5\._#[Q5J'PC\#V<-^EQI^B^'/A]>W.B7%O MIRO' T4>L>(HM:\3W*E&#WNN7+P7-U9BWF?]L?\ @VM^ PL]$^/G[2NI6-)K*_$INKB+4M0U'PA;3P&UBM8[CP]*\%Y M?S&\@TO]TP&*7A']'^>.P-?#4N(A&FJ7M(SCS*Q^78S"UN/O$[ZKC:%>644,36PRA4IU80CA,'4J4JCC*2 M24L35@ZE5*27-RN-DRNG_!L?IS G_AL;5<9^7/P'M2<8!P?^+N)_$3V.1SGG M \V^,W_!N)<_#7X3_$CQ_P"&_P!I_5/&WB+P7X%\6>*]#\'GX.6.B+XGU/PY MH=[K-KH1U<_$W5!IC:L]D;""\:PND@NKF!WBD161OZ_XN4.6SR/RW8NA!# 8;@D'^>*?CMXKT M*M&O4XPQU:G2K4)5:2P664_:T(U:4:M-NE@HSBIT(SA-PDI1C*4KJS/UZOX4 M\#NC55#)Z5*;I5(TJD<1C*D(3=.482C1]LX2?.U:-K>SO+6>&[LKF/=;SP74#I+:3*V5>"3SDB;)8F!BP.\(2W^E9^PU^T=H/[6_ M[+'PC^-5A/'/J/BGPO8V'C2U%K):?V5\0-"ABT;QSI?D2-(XM+?Q)8WRZ=+) M)(;S2'L;IB!?VT/VA?A/H&G?V/X%M+N8UA M2Q\,^+=/T_QGX=@LDDN96;3+32M?BL=-O'E8.MA%YCI>&2UB_?+_ (-N_C]$ M= ^/O[+VJ:M:_:[/4-)^,G@;2'O)3>75IJ4$/A/XBS6*")[9(+*_M/!%Y=J+ MU)VO?$$MQ#9OYUS.O] _2 P>7\6>&^1<;974PT,=EM++<:J5"MA*]>MEV:4: M4,?2G+Z[3K4ZV$Q7)6I49TI>S)?$'BSX1:I+'$UCK_P /-6U&2]TI+6XMR(&O?#\3+H6K0"*">&[L M#+Y,4$\ ;[Q_X)$?\%:+/]CDW?P,^/+WMW^SOK&I7VO>'_$.D:3ZO\ 2M7FGU.RMKJWN[J.Z_JV_;@_84^" MW[;_ ,++CP#\4],>VU_3HKZX^'WQ&TNU,OBKX?Z[>1P(VH:2#/&E]ILZV]L- M=T"^%)SX+\4:7)/(L,TVJZ3JWB_1?#^I.Z_/H&M>)VUY87$LMN-RS.^#>-N M#_&'@BEP)QM; YOA*.7X6%2O7A2YU@:'L*68Y?C)2C%XJJZ='ZQ1DYQ^.I%> MSE99\3\-\0>'G$L^)^';U<%7Q%?&TZ="E6J.C3Q$E4JX3&4X*4>2]2;BXQCN MD_>BV_[H=&_X*=_\$^-?T:'74_:X^"%M9W$<4T<.L^,;+P_J2!HMP+Z3KQTK M6[?83(F+G3[>1)8F5XXY8B%_$'_@M-_P4F_9(^/'[,\WP"^"OQ+7XG^.+[Q_ MX9UZ[G\,:!J[^&-'LO"]S/<3F_\ $FLV>EZ7>373SI';Q:&VK.&5Q=+;$!7_ M )/3(C2[O+)&\1%2)P$9MNY$F=B2)(P$5E;:$?:I)!+>S?!G]G?XY?'[7;'P MW\&?A9XX^(VHWVH6NF ^&M O+[3K*ZNI%C1M6UCRH=$T&P0,7N=6UF_T_2K1 M$:6\NX8_G7IRGP X$X/SC+^+<=Q?6K4,HQ-',L,\1/*H4>?"5?;15:MA\;3K MU$HII.-",I24(RCR*7-GF/BQQ!Q'@:N18;)L/3JXZC+"U51I8YXERG%IQ4<1 MA)TJ;YUS->W=H\R4KN*7U!_P2J8+_P %#OV3=P8$?%.R4C#,%QI6I1#G+83? M)$J$G!$D9XW"O]&U6#PN4P1M*\9X*DJP''\)5@?<8[&OPE_X)?\ _!&[P!^R M9JNC?'+XMSW_ (Y^/J:7C2],UG3-(M?#GPLO+H2QW*#:,^ MGOXG_MJ=;>QDN(=-LM.-[?/=?O 5$2D+@J22!C'4'/3N3\Q/4N6)ZXK^?O'C MC7)N.>-/[0R9UIX;#8"67?6*OLU];JQG7J3Q%-027LE'EA3=K22'.&ZE+,5RXK'8BOBG3L[PHU*:Y;II/VG-=-64;))).Y_F#_M7G'[5/[3 M/3_DX'XR]>Y_X6#KW?\ ^M_7/]27_!%/]MK]D[X%?L2:/X#^,7Q^^&WPZ\7P M?$;X@:BWA[Q-KT.GZHMG?W]M+9W#6[JQ\NX17>-@1E4)( Z_RW_M6@R?M2?M M(R(R R_'SXS2,LC+$8\_$KQ/&J.LC1M')LA60Q2!)-K[MH3!/@0ADW;O/A/4 M*/-M1L7C*JRNI92=I.XL#^* M+S2E&&(HXNE!NIC*]VY4<-7*H3W Z"(GJ0. >2! MWK_-[V2=YXA[&XM__CM-93E4:XC E)CPLT)#*RLTI)60X\J&.289*D^60C!C M7Y!7^C1PCAZ-:?\ KUC(TZ-&I-2J0R-1M"G5E%3]GC:DUS22@N6G)WDFE:Y^ M@T?''/IRI4_]7L+4=ZD=FKZJ_^JOX7\7>&O'? MA+PWXW\'ZU8^(O"7C#0](\3^&-?TR7S]/UO0->LH=3T?5;&; \VTU'3[JWN[ M9]JEH958J.@_SJO^"JO_ "D0_:R/9OBG=$8ST_L71_3Z?Y-?W9_L%L7_ &$/ MV-=P?"=G&51JS5^57>MT?LG_P0._:W_9H_9W^!7QO\ M/_'#XU>!/A?K.O?%:PU72--\5ZS'IMW?Z;#X3TZSDO+:%P3)"MU%) S=G5N, M8)_?!/\ @J%_P3Y50#^US\%*L_S3B>MQ MCB<+5SG&SQ-7"4%E$J=&I4C3BXT_:9G*NSM'\_R/Q=S?AW*<'D M=')<'B(8"ER0JR_M*\XKF=YZ/ MJ8TC5]0T'4S:7:JHE^QZQI6H:?,<#;<6DR@L &/^6+Y1$=_](MQ_P"U M<_D/QYK_ $"?^"&) _X)D_LX(GEA0?C$1L.1\_[0'Q7.#\S-]P1R*2V"DB.J ME'0G\-\6/!_)_#W(,LSC+.(L1G-3'9HLOJ86K'+DZ%-X*IB_K%\+C*\^5S@J M:3II.[?,Y>Z?J7A]XBYQQ=F^)P6-R6G@,)#!5,33Q-+V]IU88B%+E_?TZ3]F MXR;UIQJ*2VY;7_76B@45^!'[$1^5$P(:-"#R0RJPSP><@YY /Y'WJ,6MNH"I M#$BK@*J1QJJ@ 8"@+@ >G%6**EJR]WW=KVTO9.R=G&]KNV]KNVC9$H1E:\8. MU[$K7>^U^MV57@AR,H.G9$/KWP/\_6JNRU7((CR"1@QIO;H?E4Q@ ML.>"H.['!)5JNR9# \8P,Y/N0<#//7/0\^^!7\['CC]O']O*^^+'_!15/A+J M_P"S18_#W]@BYL==G\-?$?P-XRDUGQGX8N-$\6>()],3Q'X=\9V,<6NQ67@; M5S:^?86BW=UJFG6\A@R6E]'*1FN;9?D]*G4QD8J-;VBIJG1564I4:,Z\U:%&\7[. MG+E3^*7+%)N21_0Z8;3($B08ZD-%%M!!!#'*X!W8*DX[L"1DB5/L2@!!"H)1 M1M4*&^4(N, @*@0$?*JJ!]T #\4/VA/^"D'Q)\(?\$^_P!F#]L;P-HO@[PC MK_QH\=_"+2/%FD^*XKG7_#'AW0O%=GXDG\8O97GVG1I%MK:717FL=^\0F6XU.QNEOHM-A@MYK-X'$_HT MN$,ZQ,5;#.M&-?.:$Y.I%TZ%3(XU7C_:SYZE&E%JC+ZM4Q:JUHYK"-7!1IQ4(RG.TOWE-:T&I*=FF?L2UG9)G= M;P*ISG]S&!UR2<+C[S'D@'+$]R:18K>)"\,<2H"1N5$089E'7"Y&0N>@P 23 M@8_)#_@J;^V_\]L--\6Z%JF MFG;<0M>6=DTJ2)'I35.K[*NJ;O1DC>.=96L=F.!BX?7LLPCQV(4*$4_9.,IS]G5 MC3C[6HDFJM.,G)3M&7O.Y]PI+$F0)!EB#CG+' ' R3@#Y>6P01QS2-+;.,R MNC #E77<5.&)!1@2&QD$8R#\C $@'^<_X)_\%'?VS(]2_85\5_%?6_V5_'WP M^_;0\8Z)X+N/ 'P]T'Q9X:^.'@$Z]]IM(O%"6-QXRUG3-3\.:#>K93^*=0FT M\06B7UA8+#;RZI#?0_1'[?W[?WQB_95_:R_9E^'?AG1_"6I?!3Q5INA^+/V@ M=3U+1-0NM?\ "'@75/BWX7^&UUXHL-8M=7M$TVTT^;Q/IT$<;V%XLVJ7EC%, MT<$KX]7_ %&SJ.9T\HI_5ZN*J8;-,1"<,7!T7'*?;0S"FZE2-%>VHU*8N,"; MGX27>I_"[PI\7M=U/P]JVI>*K7QS\5=-UOQ%H>CZ??P:Q;:?I,%QX970+RRE MET^_:2:;5Q<9CMT2+Z*_X*6_MB?%W]G'P[\*OA[^S'H/A_QU^T[\9_$&O2> MO NO:/J&O6]]X&^'7A;5?&'Q#UF.UT[4=+$EY9VMMI.E:?9W-_!+?7&JO)81 M3II]^T/GT^%\XE6R' -THU>(<#2QF"A5K484J>&JSG2C]?E*HZ6!<'']]#$) M*E&47.RDD=#XERBG1S7&I7CD^*EA<94I8?VM1UK0YOJSC3=7%1FIQDITI-3C M%N[46?J=BVE;9B.4QG.THKE'4@@EB"%<'!7D$X)7A3B)X+5C)&\,#;\J5:)& M!S\QW!A@@[B2>Y+#.0U?!GPR_;4T;7?V -#_ &V];AM;K3X?@'+\4_%NCZ1; MW$*+XG\+Z!<#QGX5T9)V9PR^,](UCP]I2N71KF6!FD:,%W^&O@Q\>O\ @L1\ M9_ GPZ_:@\+?#[]D6X^%GQ1NO#WB+1?@5ZHEOX?FQIY!BY4L57K5<-EU/+<=4RZ M4L7B*>'Y\PINJGA,.I?Q*KI495X*FXIT)4JO-&-2%^JMGF#YL/1HTL1CIXS# M4L8J6&P\ZU\-6CI4J)>ZN23Y*D)WE"2<6KH_:";X6?"UYVO+KX=> YKR259' MNI?!_A^:=I#G$LD[:<\@(._]Z[@*3@N,C/9VT6FVL445M#;6]M'$L,$4$"0P MQQ*J[(8EB58U4+M585 ' 55!7;7XE?\ !0']N7XY? G]KCX!? ;P!\2_V?O@ MKX*^*/PR\5^+?$OQ/^/VE:I=^%/#VI>';GQ!=67VK4(?&?A2SLH]7BT:VTNR MC>5Y)+^]59)G2/[./>/$'[2?QB\"_P#!.KXN?M*M\5/@#\;_ (@^#_!?CGQ5 MX,\??![2[V;X.ZXFA7[Z790BQ_X2G5Y]2;2KVSO],UF-?$1C>]M60K$5*UT8 MCA_-%A,KQ.)J3JTLY5*6!4IUZE.K[>K4HP7MIREAH35J;QZO='ZB![3=N5H58@ MD-@*YY"DY;:1NR%!/WP2!D9IX:-QG=P#]UE*MT[J^"#@GL.".QY_&CX__MV? M&OX+U M\*Z?_;MO<:3:EJGV.T+0W*:A,5F6S_P %0OVB/VS_ -DKX;^) M/VA_@OXG^!Q^$_A:U\$:'=^"O&_@;Q=K7C>\\4>)?%$7AR34;;7=)\8:#HZZ M1LU+3+E+2:QDO56VO&>Z*RP"*<'PKF&,Q&5X6C4P>&GF^-S'+< L37H4:=3& MY9B7A,92=2=XTW&K?DYK0J4U*I%N+=],7Q%@<-3Q->2Q%:G@L-AL5B94:56I M*CAL53C4HU7&+;]G)22YD])WC:Z9^P1BT\-DPP!SP&^SJ"P.3@,%&=QW;<$[ MF/&XD"I1%:^7N6*$(0"I\M%X/U'!).,$9)XZ\G\ROB!\4_VO?V?_ -A_]H7X MX?%[Q9\%/&OQ6\#^!]:\'_!EGIUMI=@]G8>)M#U?Q1?W.L7@ MU%[^266UU*TMY+/[)%Y?F)++-Y]\;_\ @H=\1O@_^P%^R]\?M+\#^&O'/Q__ M &F_#W[/>@>"/ ZC4-(\)7WQ1^,?@:U\57@D6+4)=0L/#%A-'?PVL$VJ!DEE MTRPO=:A6XFU&'##Y%C\7B*.%PU6&,GB*HX?$8JHU4]HHQH0H M83$2=9\E.*@UHVD*MG.78:C7Q&(P\J"HX#^TI\V&2G]7=>A0NU[)R=2=;$T( MJ#;E)S3N[-GZ[*MF1D+"W4@"(.W&"0H526;D?)@O[<'$,T=@ZINB@D0ELAK= M7!&P$\&,CE6P5.2'_ (N^%-&_::TS]EGQY\&/%6C: MS>^*O%GPD_X2OP_XH^&_B*WT=KC2-"M]-\1W$:>+['4]7*Z5'##I\\T%JE[J MVI>(+![.'3=4\#_X* ?\%%/C7^SC\>O#G@SX,:!X)\3?#?X1>%?"'Q6_;%O] M7T_4-4UWPG\-/''Q1\,^!-"L_#[6&J6K:;XDDL+O6=9:R^PZS-%H\]MXBDL5 MT_3KR.XO Y#B\PQ\LMRW%X+$U*>%K8MXBGF5'ZI3HX>$Y2Y\74JQI1JRE%T* M-*=IUL3*EAZ=ZE2%S$9W@,%@7CL?AJ^'C]8I85T*N"?M9UJL8S2I4I4I.K2C M3G&/?V6?V+?%_[0OP:?PI MJWB?3-1^'$6AS>);"XU[P[=:;XO\7Z-HUY.MOIVJZ;).LFFZD\MC<6VI!%F$ M$VZ>)=DGW5/XBU#3/!]QXAMM)N=:NK;PY=:VNCZ9&TFH:O?0:5TY-^QG]FE7DW3G/VGO?NYM=T,QP->O6P=TZE#!40<;3UZ_P J_GU_8A_;H_;._:V\2>!O%OAKXE_L9:]HE]XS6+XV M_LW6]AX^\/?&CX*?#%?$;:9+XAL+S4O$,]QXI\16]@L3SS2Z.^@7.J7.GV%O M>;;RY33?Z"[.02VT4BXPZ!@5 52&^8%0"1M(.002&!W#@BMLVRC&9-BG@\96 MA/$17[R%*I*HJ4ERWA.<9*/,N>/*XNI3JQO4HU:E/WGGEF88/-J=2OA*%J5. M<:;J3H0IJ4IP*L]&KL0V=J>L$!..28DS@9Y]A_+VJ2*&&(# MRH8XP%(&Q$4 ,Q8@;>@+$L0."3DDFIL8_P#UD_SHKS;-VO)M)II.4FKJ]FDY MR2:N[.UU=I.S/4C3IP;<80BWHY1A"+:O?5QA%M/2]VPHHHIEA0?KBBB@"O*3 MN/'RA02/7G'7' YYP>WXC\)_A!_P3 T#QW^V-^W7\6?VJO@YX<\7?#WXG>/_ M (?^)/@;_:WBB:_L=6TVP3QA_P )1+K7A?PWXAMX,"5O!%S&O@'BH*HL)5=>G"482A*;A*G^\4D^:-I7Y7HVD>\_\%-OV M1_&7QZ_9F^%/P4^!'@3PM_#RX>P\1Z!X2L_"%W>V.E6&D:KXK>QNH/$$-M%8B_ M:P6^N&E4"[4 HKT,'Q'FN!HX?#8?$3A1P[S&4*:E/D;SJC+#X[VL>9QK.<:D MI0E5525.IRSBTXHX<5D.6XFO4Q%6A!U:CP?%WQ;\2O&G[-GPW^%7PZT+X9_L^Z[\.=6\&: M]XC\;67B=M:OOBKK&K6%X==?PK%J-U=VNB7-M)!IVK:WH,-A;33BWDU&*N@_ M8^_9+^/'[-_[-/[6_P"QWK.D/KO@.SN_BA;_ ++?C>^\4:%-J/B[PE\2?#^M M+;Z!K>FV]Z[>&M0T/Q*ZWM_=:D+.TU*Y\2WE\L-M% Z,45K7XLS:CEN%RYO# M3P6"J994P6'^K4J2PE;*,32Q&"K4JE"%.JZD:F%C[7VDZD*RJ5E.'[R1E_JY MEL<36Q\8U5B\4L7&O6]K)NI#&I1KPDF[_9A M\3?L(?M(?#;X1^$;KXM?#?PM)\.?VJOA:FL>"[?^V],\1)X@MKWXK>&/%E[K M'_"/3^.M M-0M1)_9FHVU[K-I::3I,=[#I@UNSOOMW]L3]B[QO\ M,?M%^-- M:GT6P'PQU_\ X)__ !9^!ND>(9-4TTW&E_&[Q5\1=!\1>$;BXT.2ZBU&>ST> MTTJW\0P:@L*V=O>6-JLUS"Z"BBC%K@XXN=2NZOU;$ MXJ6,E1:4]XH^&/AY_P3M_:[TSPK^QOX\\>:'I?B?]HO1_V[?! MWQY_:<\3W_B?PS?:U9?#7P?#IG@K2C+XFFOXSXH-GX'\/6VHVFB:3<7DNG:C MX@U1XK47EQ>.?K/]H+]A/X^?M3_MYR?&V\^+'C']GCX9?!SX/^'_ /\$?&O MPZU/P]?>,?$/BGQ+)K6I_$/4XH;IKVY\*ZK)1_L^?MP_L/?M1U#X)?$'Q!XT@_9\^)NHZQH& MNZR_A;XEZ)JVF:O-<^%=+N43PS=:+X@MM+\<7.DG3],TS6_$GB'Q%/8Q6T>I M,L&/\!?"?_!6_P"#/@SX9_LDZ5\-?@/%X-^%7_"+^&K#]K;5_&]OJ^BZQ\,O M#&LVC6WAV#X0Q+!XZ'BJ3PO;#PN+R[MK*SCM5:>#4K765AUR(HKAQ7&N/E4Q ME/%8'+<;#-\51Q5:.(I55&ACZ.#H8&./P\*56$8XF>%P].G5YU.E4ES594_: M2 ?B3XJ\"Z M#X;UC6O$TGB*TLX[VU\76FMQ7O\ 8Z:C%XBMIX]!NX!JMG8QK-$QVV_U1IOP M5^*'QS_8/^+O[._C[X#_ W_ &1_$GC?PI\0O!7A'P!\/O$6@^)_ WA^UU^P MN-3T;Q C^"M(T72+JZ^(FLTI5HXFFXX=0_?4(PDX.-)232BI*[:4_>W/SP\.?LC?\ !0SX^^%/ MV./V3OCS\)_AE\'O@O\ L<^//A-XUO/CAI/Q'TOQO=_%FT^!_ARY\'>&-)\) M>#=+NUUK0KK5]%U"Y%]?>)[?3DMKJ%=0CE)M[?3;[]'/^"J_[.WQ4_:>_8N^ M(/P2^#FB67B#Q[XB\0_#W4-,L;[6-,T&S:PT'QSHNLZC)/J>LW=K:1M:Z983 MR*K2HT[((XPSFBBNJMQ5CL1F66XZ.'P6&ED>*QV+P%##4I4\/#&9C6EC<;BI MQW-R4X)0IQA'0YZ7#>#HY7BL$ZV(K1S&%&CB:M5TW6EAL/&%*CA ME*,8I4H1IIK3FYFY-W9[#^VA\)_''QB_8P^.7P9\"Z?;:AX\\<_";5?"7ARP MN[^UTVSN]:N;.!(H9=0NY(K2V@#ET>XFD2)/+RSJ#Q\5_&?]@7XM?&O_ ()U M_L<_"/1=:T?X:_M&_LP>&OVW\,ZEX8U:_T;^TD M&G2:K=7!;4[)+ZUDGTNU,BBQN;F9"BO/PW$&.RB6$Q&"5*G/"9C/-:*E%SC] M;KT,10K.:;]^G4HXO$4Y4Y-Q:J7MS)-=>)R+"8^>*I5Y573K9O_LY^-?^"E7Q'^)^C7O[0_P.^"W[/'PA\(V>L6?B MG1M-\;1?$WQS\3]=?31;:'K_ (/FT+5+O2_"'A+3-0"37=MXFGD\37=LL]FU MH9YX7'P)_P .K_VA/V@O%?[;/Q9^,?QH\=_ W6_VC?B#XGT[3OACX)UCPEXI M\.^-O@_X>TM-/^%6G?$74Y%OFDM[.TN)-,N=$TR]TE=.M].E=I6O&M[FV**[ ML%QAC\KJXFOE.#RW+9XF&$PT_886-1*E@\;',*:7UGVW,ZF)FY5G-2=6FHTF MU"*MS8CA;!XNGA:6.Q6.QT,.\17IK$58M^TQ%)TYN3A&+?+"$8TMO9I>[NSK M?B+^R#^V)\4_^"..A_LC>(/!-A=?M%^%)?!OABVT*X\;>&+RPU#PAX$^)]K= M>&[]/$MSK+Z*GV?P%I5C;_8K[4_MR7&G/;M;2$('_1+]G[Q_^V]XN\/^.M*^ M-?[,_P .O@/K^A^%K"'X6:J_QAL?B;H_B/Q1)9:A;F+Q99>%K&VU'2="M=0M MM+N+F:V>YNKB"YN8EB$B"9RBL,3Q3B,9A<1@\1E^6S@\WQV<1J>QK*I3QF9N M,\7[-1KJG&A.5.\:'L_9TU.<8*,65@N'Z5+%4L30QV/HN& IX!TX5*3A4I4& MU3E-SISFZBC/E;4DFHQNKIGY=+^QA^UU\=?VJ/V>_B'\0?V4OV>OV6M>^ OQ MET3XE?%#]IWX,>.-%EO_ -HRPTN\$NKZ#I7A+P[I]AXMT_3_ !:$N7OYOB3) MQH-TCJRC(L/D\<95I8C$XFKCL1&I7J8F5.4FZ,)4X**IPA&,5&332BK 1OWG=W+5%%%><>P%%%% '_]D! end XML 7 R1.htm IDEA: XBRL DOCUMENT v3.23.3
Cover
Nov. 27, 2023
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Nov. 27, 2023
Entity File Number 001-36306
Entity Registrant Name Eagle Pharmaceuticals, Inc.
Entity Central Index Key 0000827871
Entity Tax Identification Number 20-8179278
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 50 Tice Boulevard
Entity Address, Address Line Two Suite 315
Entity Address, City or Town Woodcliff Lake
Entity Address, State or Province NJ
Entity Address, Postal Zip Code 07677
City Area Code 201
Local Phone Number 326-5300
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.001 per share
Trading Symbol EGRX
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
XML 8 tm2331615d2_8k_htm.xml IDEA: XBRL DOCUMENT 0000827871 2023-11-27 2023-11-27 iso4217:USD shares iso4217:USD shares false 0000827871 8-K 2023-11-27 Eagle Pharmaceuticals, Inc. DE 001-36306 20-8179278 50 Tice Boulevard Suite 315 Woodcliff Lake NJ 07677 201 326-5300 false false false false Common Stock, par value $0.001 per share EGRX NASDAQ false EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.3 html 1 23 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://eagleus.com/role/Cover Cover Cover 1 false false All Reports Book All Reports egrx-20231127.xsd egrx-20231127_lab.xml egrx-20231127_pre.xml tm2331615d2_8k.htm http://xbrl.sec.gov/dei/2023 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "tm2331615d2_8k.htm": { "nsprefix": "egrx", "nsuri": "http://eagleus.com/20231127", "dts": { "schema": { "local": [ "egrx-20231127.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "labelLink": { "local": [ "egrx-20231127_lab.xml" ] }, "presentationLink": { "local": [ "egrx-20231127_pre.xml" ] }, "inline": { "local": [ "tm2331615d2_8k.htm" ] } }, "keyStandard": 23, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 59, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 23 }, "report": { "R1": { "role": "http://eagleus.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "AsOf2023-11-27", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "tm2331615d2_8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-11-27", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "tm2331615d2_8k.htm", "first": true, "unique": true } } }, "tag": { "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://eagleus.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r2" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://eagleus.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://eagleus.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://eagleus.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://eagleus.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://eagleus.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r13" ] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://eagleus.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://eagleus.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r17" ] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://eagleus.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://eagleus.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r10" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://eagleus.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r2" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://eagleus.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://eagleus.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r15" ] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://eagleus.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://eagleus.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r9" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://eagleus.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1" ] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://eagleus.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r16" ] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://eagleus.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r14" ] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://eagleus.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r13" ] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://eagleus.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r18" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://eagleus.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r14" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://eagleus.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://eagleus.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r7" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://eagleus.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://eagleus.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://eagleus.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r0" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://eagleus.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://eagleus.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://eagleus.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r13" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://eagleus.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r5" ] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://eagleus.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://eagleus.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://eagleus.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://eagleus.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://eagleus.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r8" ] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://eagleus.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r2" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://eagleus.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r4" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://eagleus.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://eagleus.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://eagleus.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r2" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://eagleus.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://eagleus.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://eagleus.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://eagleus.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://eagleus.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r11", "r13", "r14" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://eagleus.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r19" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://eagleus.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://eagleus.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r3" ] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://eagleus.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://eagleus.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r14" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://eagleus.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r2" ] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://eagleus.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r12" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://eagleus.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://eagleus.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://eagleus.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r2" ] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://eagleus.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://eagleus.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r6" ] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://eagleus.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 15 0001104659-23-121848-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001104659-23-121848-xbrl.zip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